.jpg?format=webp&width=780)
An outbreak of mpox (formerly known as monkeypox) disproportionately affected transgender persons and men who have sex with men in the United States. The JYNNEOS vaccine was approved for preventing mpox in 2019. A case-control study using electronic health record data was conducted to assess the vaccine's effectiveness. The study found that receiving two doses of the vaccine provided 66.0% effectiveness in preventing medically attended mpox, while one dose provided 35.8% effectiveness. The study concluded that the JYNNEOS vaccine was effective in preventing mpox, with better protection observed with a two-dose series.
Like
Save
Share